CDLX

$2.090.72%0.015

Cardlytics Inc (CDLX)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$2.08

Offen:

$2.08

24-Stunden-Volumen:

117,780

Relatives Volumen:

1.20

Marktkapitalisierung:

$12.31M

Einnahmen:

$205.69M

Nettoeinkommen (Verlust:

-$104.00M

KGV:

EPS:

-$20.33

Netto-Cashflow:

-$3.60M

1W Leistung:

+24.40%

1M Leistung:

-17.39%

6M Leistung:

-77.15%

1Y Leistung:

-89.00%

1-Tages-Spanne:

$1.97$2.21

1-Wochen-Bereich:

$1.57$2.21

52-Wochen-Spanne:

$1.57$19.50

Cardlytics Inc Aktie (CDLX) Unternehmensprofil

Firmenname

Cardlytics Inc

Sektor

Communication Services

Branche

Advertising Agencies

Telefon

888-798-5802

Adresse

675 PONCE DE LEON AVENUE, NE, ATLANTA, GA, USA

Mitarbeiter

275

@cardlytics

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

SEC

CDLX-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Cardlytics Inc Aktie (CDLX) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2024-10-11	Eingeleitet	Evercore ISI	In-line
2024-08-16	Herabstufung	Northland Capital	Outperform → Market Perform
2024-08-15	Herabstufung	BofA Securities	Neutral → Underperform
2024-08-08	Herabstufung	Craig Hallum	Buy → Hold
2024-08-08	Herabstufung	Lake Street	Buy → Hold
2024-08-08	Herabstufung	Needham	Buy → Hold
2024-06-20	Resumed	BofA Securities	Neutral
2024-06-18	Eingeleitet	Northland Capital	Outperform
2024-03-15	Hochstufung	Craig Hallum	Hold → Buy
2023-11-29	Eingeleitet	Lake Street	Buy
2022-09-08	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-07-14	Herabstufung	Wells Fargo	Overweight → Equal Weight
2022-07-13	Herabstufung	BofA Securities	Neutral → Underperform
2022-07-12	Herabstufung	Craig Hallum	Buy → Hold
2022-04-05	Resumed	Wells Fargo	Overweight
2021-06-18	Eingeleitet	Needham	Buy
2021-04-15	Hochstufung	Wells Fargo	Equal Weight → Overweight
2021-04-14	Hochstufung	Craig Hallum	Hold → Buy
2021-03-05	Hochstufung	BofA Securities	Underperform → Neutral
2021-01-14	Herabstufung	William Blair	Outperform → Mkt Perform
2020-08-28	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-04-21	Herabstufung	BofA/Merrill	Buy → Underperform
2020-03-04	Herabstufung	Craig Hallum	Buy → Hold
2020-01-15	Herabstufung	Raymond James	Outperform → Mkt Perform
2019-12-02	Eingeleitet	Craig Hallum	Buy
2019-11-14	Herabstufung	JP Morgan	Overweight → Neutral
2019-08-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2019-07-24	Bestätigt	BofA/Merrill	Buy
2019-07-01	Eingeleitet	William Blair	Outperform
2019-01-15	Hochstufung	BofA/Merrill	Neutral → Buy

Finanzdaten der Cardlytics Inc-Aktie (CDLX)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	233.27	278.30	309.20	298.54	267.12
Research and development USD (M)	39.77	49.61	51.35	54.44	38.10
Operating expenses USD (M)	335.09	473.80	444.87	756.32	389.72
Operating income USD (M)	-101.82	-195.50	-135.67	-457.78	-122.60
Income before tax USD (M)	-103.49	-189.30	-134.70	-466.71	-136.43
Income tax expense USD (M)	0.00	0.00	0.00	-1.45	-7.86
Net income USD (M)	-103.49	-189.30	-134.70	-465.26	-128.57
Basic EPS USD/shares	-1.95	-3.91	-3.69	-13.92	-
Diluted EPS USD/shares	-1.95	-3.91	-	-	-
Basic weighted shares shares (M)	53.11	48.36	36.49	33.42	-
Diluted weighted shares shares (M)	53.11	48.36	-	-	-

Cardlytics Inc-Aktie (CDLX) Insiderhandel

Gupta AmitOct 02 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$2.53
#Aktien
7,382
Wert ($)
18,699
#Aktien Gesamt
138,906
Gupta AmitOct 02 '26
Officer
Transaktion
Proposed Sale
Kosten
$2.53
#Aktien
7,382
Wert ($)
18,701
#Aktien Gesamt
0
Gupta AmitOct 01 '26
Officer
Transaktion
Proposed Sale
Kosten
$2.71
#Aktien
10,351
Wert ($)
28,051
#Aktien Gesamt
0
Gupta AmitOct 01 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$2.71
#Aktien
10,351
Wert ($)
28,051
#Aktien Gesamt
146,288
Gupta AmitAug 18 '26
Officer
Transaktion
Proposed Sale
Kosten
$4.03
#Aktien
6,676
Wert ($)
26,908
#Aktien Gesamt
0
Gupta AmitAug 18 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$4.03
#Aktien
6,676
Wert ($)
26,911
#Aktien Gesamt
125,389
Gupta AmitAug 17 '26
Officer
Transaktion
Proposed Sale
Kosten
$3.97
#Aktien
6,785
Wert ($)
26,909
#Aktien Gesamt
0
Gupta AmitAug 17 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$3.97
#Aktien
6,785
Wert ($)
26,909
#Aktien Gesamt
132,065
Gupta AmitJul 06 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$4.39
#Aktien
9,640
Wert ($)
42,358
#Aktien Gesamt
113,850
Gupta AmitJul 06 '26
Officer
Transaktion
Proposed Sale
Kosten
$4.39
#Aktien
9,640
Wert ($)
42,362
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Gupta Amit	Chief Executive Officer	Oct 02 '26	Sale	$2.53	7,382	18,699	138,906
Gupta Amit	Officer	Oct 02 '26	Proposed Sale	$2.53	7,382	18,701	0
Gupta Amit	Officer	Oct 01 '26	Proposed Sale	$2.71	10,351	28,051	0
Gupta Amit	Chief Executive Officer	Oct 01 '26	Sale	$2.71	10,351	28,051	146,288
Gupta Amit	Officer	Aug 18 '26	Proposed Sale	$4.03	6,676	26,908	0
Gupta Amit	Chief Executive Officer	Aug 18 '26	Sale	$4.03	6,676	26,911	125,389
Gupta Amit	Officer	Aug 17 '26	Proposed Sale	$3.97	6,785	26,909	0
Gupta Amit	Chief Executive Officer	Aug 17 '26	Sale	$3.97	6,785	26,909	132,065
Gupta Amit	Chief Executive Officer	Jul 06 '26	Sale	$4.39	9,640	42,358	113,850
Gupta Amit	Officer	Jul 06 '26	Proposed Sale	$4.39	9,640	42,362	0

Cardlytics Inc Aktie (CDLX) Neueste Nachrichten

Oct 23, 2026

Cardlytics, Inc. Common Stock Estimates – NASDAQ:CDLX - TradingView

Oct 23, 2026

Oct 02, 2026

Form 4 Cardlytics Inc For: 2 October By Investing.com - Investing.com South Africa

Oct 02, 2026

Form 4 Cardlytics Inc For: 2 October By Investing.com - Investing.com India

Oct 02, 2026

CEO Amit Gupta also sells 7,382 shares on October 2 at Cardlytics (CDLX). - Stock Titan

Oct 02, 2026

A proposed 7,382-share sale at Cardlytics (NASDAQ: CDLX) includes coverage of an equity-award tax bill. - Stock Titan

Oct 02, 2026

Sep 18, 2026

Cardlytics, Inc. Common Stock CDLX Stock Forecast & Price Target - Yahoo! Finance Canada

Sep 18, 2026

Sep 17, 2026

Cardlytics stock jumps after reverse split and strong recent gains - AD HOC NEWS

Sep 17, 2026

Sep 05, 2026

Cardlytics (CDLX) Latest Quarter: EPS Beats Its Estimate in the Latest Session; Latest Reaction: The Stock Closes Near Unchanged for the Current Session - Post-Earnings Reaction - vinanet.vn

Aug 24, 2026

Cardlytics (CDLX) revises an earlier insider stock filing - Stock Titan

Aug 24, 2026

Aug 23, 2026

Cardlytics (CDLX) Results Check: The EPS Result Is Above Expectation for the Current Session; Shares Show Little Net Change in Latest Trading - Earnings Analysis - siam.in

Aug 23, 2026

Cardlytics (CDLX) Results Check: The EPS Result Is Above Expectation for the Current Session; Shares Show Little Net Change in Latest Trading - Capex Guidance - vinanet.vn

Aug 23, 2026

Cardlytics (CDLX) Results Check: The EPS Result Is Above Expectation for the Current Session; Shares Show Little Net Change in Latest Trading - Negative Surprise Momentum - dars.gov.et

Aug 23, 2026

Aug 19, 2026

Cardlytics (CDLX) Results Breakdown: EPS Clears the Reported Estimate in the Latest Session; Market Response: Shares Move Higher 1.73% in the Current Update - Upward Estimate Revision - vinanet.vn

Aug 19, 2026

Cardlytics (CDLX) Results Breakdown: EPS Clears the Reported Estimate in the Latest Session; Market Response: Shares Move Higher 1.73% in the Current Update - Banking Earnings Report - dars.gov.et

Aug 19, 2026

Aug 18, 2026

Cardlytics CEO Amit Gupta disposes of 13,461 common shares for $53,974 - Bitget

Aug 18, 2026

Cardlytics (CDLX) CEO sells shares outside 10b5-1 plan - Stock Titan

Aug 18, 2026

Cardlytics (CDLX) insider plans sale including tax-cover shares - Stock Titan

Aug 18, 2026

Klarna stock plunges 20% on trimmed guidance as German retail sales slow - AOL.com

Aug 18, 2026

Cardlytics CEO Amit Gupta disposes of 13,461 common shares for $53,974 - Bitget

Aug 18, 2026

Aug 17, 2026